DKK942.00
0.02% today
Copenhagen, Sep 16, 04:59 pm CET
ISIN
DK0060448595
Symbol
COLO B
Sector

Coloplast A/S B Target price 2024 - Analyst rating & recommendation

Coloplast A/S B Classifications & Recommendation:

Buy
28%
Hold
52%
Sell
20%

Coloplast A/S B Price Target

Target Price DKK911.36
Price DKK942.00
Deviation
Number of Estimates 22
22 Analysts have issued a price target Coloplast A/S B 2025 . The average Coloplast A/S B target price is DKK911.36. This is lower than the current stock price. The highest price target is
DKK1,060.00 12.53%
register free of charge
, the lowest is
DKK700.00 25.69%
register free of charge
.
A rating was issued by 25 analysts: 7 Analysts recommend Coloplast A/S B to buy, 13 to hold and 5 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2025 of . Most analysts recommend the Coloplast A/S B stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '23 2024
Estimates
Revenue Billion DKK 24.50 27.02
8.51% 10.27%
EBITDA Margin 32.07% 31.91%
6.75% 0.51%
Net Margin 20.40% 18.83%
7.59% 7.70%

23 Analysts have issued a sales forecast Coloplast A/S B 2024 . The average Coloplast A/S B sales estimate is

DKK27.0b
Unlock
. This is
2.72% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK27.2b 3.40%
Unlock
, the lowest is
DKK26.9b 2.32%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 DKK24.5b 8.51%
2024
DKK27.0b 10.27%
Unlock
2025
DKK29.3b 8.41%
Unlock
2026
DKK31.8b 8.56%
Unlock
2027
DKK34.5b 8.49%
Unlock
2028
DKK38.8b 12.51%
Unlock

22 Analysts have issued an Coloplast A/S B EBITDA forecast 2024. The average Coloplast A/S B EBITDA estimate is

DKK8.6b
Unlock
. This is
2.99% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
DKK8.9b 6.28%
Unlock
, the lowest is
DKK8.2b 1.71%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 DKK7.9b 1.18%
2024
DKK8.6b 9.70%
Unlock
2025
DKK9.7b 12.21%
Unlock
2026
DKK10.7b 11.03%
Unlock
2027
DKK11.9b 11.06%
Unlock
2028
DKK13.7b 15.26%
Unlock

EBITDA Margin

2023 32.07% 6.75%
2024
31.91% 0.51%
Unlock
2025
33.02% 3.48%
Unlock
2026
33.78% 2.30%
Unlock
2027
34.58% 2.37%
Unlock
2028
35.42% 2.43%
Unlock

18 Coloplast A/S B Analysts have issued a net profit forecast 2024. The average Coloplast A/S B net profit estimate is

DKK5.1b
Unlock
. This is
0.88% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
DKK5.3b 5.71%
Unlock
, the lowest is
DKK4.9b 2.10%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 DKK5.0b 0.27%
2024
DKK5.1b 1.79%
Unlock
2025
DKK6.0b 17.29%
Unlock
2026
DKK6.8b 13.77%
Unlock
2027
DKK7.9b 15.91%
Unlock
2028
DKK9.2b 17.11%
Unlock

Net Margin

2023 20.40% 7.59%
2024
18.83% 7.70%
Unlock
2025
20.37% 8.18%
Unlock
2026
21.35% 4.81%
Unlock
2027
22.81% 6.84%
Unlock
2028
23.74% 4.08%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '23 2024
Estimates
Earnings Per Share DKK 22.21 22.61
0.27% 1.80%
P/E 41.66
EV/Sales 8.53

18 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

DKK22.61
Unlock
. This is
0.89% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
DKK23.69 5.71%
Unlock
, the lowest is
DKK21.94 2.10%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 DKK22.21 0.27%
2024
DKK22.61 1.80%
Unlock
2025
DKK26.52 17.29%
Unlock
2026
DKK30.17 13.76%
Unlock
2027
DKK34.97 15.91%
Unlock
2028
DKK40.95 17.10%
Unlock

P/E ratio

Current 42.02 23.92%
2024
41.66 0.86%
Unlock
2025
35.52 14.74%
Unlock
2026
31.22 12.11%
Unlock
2027
26.93 13.74%
Unlock
2028
23.00 14.59%
Unlock

Based on analysts' sales estimates for 2024, the Coloplast A/S B stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.77 9.08%
2024
8.53 2.69%
Unlock
2025
7.87 7.76%
Unlock
2026
7.25 7.88%
Unlock
2027
6.68 7.83%
Unlock
2028
5.94 11.12%
Unlock

P/S ratio

Current 8.06 12.38%
2024
7.84 2.64%
Unlock
2025
7.24 7.76%
Unlock
2026
6.67 7.88%
Unlock
2027
6.14 7.83%
Unlock
2028
5.46 11.12%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today